Zdrowie i gospodarka · 06/04/2016
FDA Amends Endocrinologic and Metabolic Drugs Advisory Committee Meeting Notice
The FDA is updating the meeting details of the Endocrinologic and Metabolic Drugs Advisory Committee, originally scheduled for May 24, 2016, following a change in the meeting date.
Source: Federal Register — Food and Drug AdministrationOpen original release →